A ctivation of plasma membrane phospholipase (PL)Ccoupled receptors by vasoconstrictor agonists leads to phosphatidylinositol 4,5-bisphosphate (PIP 2 ) hydrolysis and the generation of inositol-1,4,5-trisphosphate (IP 3 ) and diacylglycerol. 1 In vascular myocytes, diacylglycerol (DAG) activates protein kinase (PK)C, leading to the phosphorylation of a wide variety of proteins, including ion channels. 2 4, 5 However, the functional signaling mechanisms by which IP 3 Rs and TRPC channels communicate in arterial myocytes are unclear.
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The mammalian TRP channel superfamily is encoded by at least 28 different genes that are subdivided into 7 families. 6 These families encode ion channels with diverse ion selectivity, modes of regulation, and physiological functions. 6 Vascular myocytes express at least 4 TRP families, including TRPC, TRPM, TRPV, and TRPP. [7] [8] [9] [10] These channels regulate arterial myocyte membrane potential, [Ca 2ϩ ] i , contractility, and proliferation, and are implicated in the etiology of vascular diseases. 4,8 -12 Given the diversity of vascular myocyte TRP channels, it has become important to identify signaling pathways that specifically regulate individual channel isoforms and to determine whether individual TRP channel isoforms perform distinct physiological functions. For instance, arterial myocytes express multiple TRPC isoforms, including 1, 3, and 6, but whether signaling pathways specifically regulate individual members and what the mechanisms are that mediate such effects are poorly understood. 9, 10 In cerebral artery myocytes, vasoconstrictors activate TRPC3, 4, 9, 13, 14 whereas intravascular pressure stimulates TRPC6. 9, 10 Thus, TRPC3 and TRPC6 channels perform distinct physiological functions, but signaling pathways that mediate this differential regulation are unclear.
Here, we studied mechanisms by which IP 3 R1, the principal molecular and functional arterial myocyte IP 3 R isoform, 5 stimulates TRPC currents in resistance-size cerebral arteries. Data suggest that IP 3 R1 is in close spatial proximity to, and associates with, TRPC3, but not TRPC6 or TRPM4 channels. Endothelin (ET)-1, a PLC-coupled receptor agonist, and IP 3 alter the interaction between the IP 3 R N terminus and the TRPC3 channel C terminus, leading to channel activation and vasoconstriction. Data indicate that IP 3 R1 selectively couples to TRPC3 channels because of the close spatial proximity of these proteins and that this mechanism is essential for mediating ET-1 and IP 3 -induced vasoconstriction.
Methods

Tissue Preparation
Animal protocols used were reviewed and approved by the Animal Care and Use Committee at the University of Tennessee Health Science Center. Sprague-Dawley rat (Ϸ250 g) resistance-size cerebral arteries and myocytes from these arteries were isolated as previously described. 4 
Immunofluorescence Resonance Energy Transfer
Paraformaldehyde-fixed myocytes were incubated with primary antibodies: mouse monoclonal anti-IP 3 R1 and rabbit polyclonal anti-TRPC3, rabbit polyclonal anti-TRPC6, or rabbit polyclonal anti-TRPM4. Cells were then labeled with secondary antibodies: Cy3-conjugated donkey antimouse for IP 3 R1 and Cy2-conjugated goat anti-rabbit for TRPC3, TRPM4, or TRPC6. Fluorescent images, acquired using a Zeiss LSM 5 Pascal confocal microscope, were background-subtracted and normalized fluorescence resonance energy transfer (N-FRET)-calculated using the method of Xia and Liu. 15 
TRPC Channel Knockdown
Silencing vectors that express TRPC3-(TRPC3shV), TRPC6-(TRPC6shV), or scrambled control (scrm) short hairpin RNA were inserted into cerebral arteries using reverse permeabilization, as previously described. 16 
Coimmunoprecipitation
Arterial lysate was incubated with control mouse IgG or IP 3 R1 monoclonal antibody and then incubated with protein A sepharose beads. Protein samples were then analyzed by Western blotting using mouse monoclonal anti-IP 3 R1, mouse polyclonal anti-TRPC3, rabbit polyclonal anti-TRPC6, and horseradish peroxidase-conjugated secondary antibodies.
Surface Biotinylation
Membrane expression of TRPC3 channels was measured using surface biotinylation of intact arteries, as previously described. 17 
Cell Culture and Transfection
HEK293 cells were transfected with vectors encoding recombinant TRPC3 or TRPC6, kindly provided by Dr James Putney (National Institute of Environmental Health Sciences) and Dr Jochen Reiser (University of Miami, Fla), respectively. Electrophysiology and Western blotting experiments were performed 36 to 72 hour after transfection.
Polymerase Chain Reaction
RT-PCR was performed on pure populations of Ϸ100 selected cerebral artery myocytes, as described previously. 18 
Patch-Clamp Electrophysiology
Membrane cation currents were measured in arterial myocytes and HEK293 cells using the conventional whole cell patch-clamp configuration, as performed previously. 4, 5 
Pressurized Artery Diameter Measurement
Arterial diameter was measured using pressurized artery myography, as described previously. 18 
Statistical Analysis
Data are expressed as meanϮstandard error of the mean. Statistical significance was calculated by using Student's t-tests for paired or unpaired data or ANOVA followed by Student-Newman-Keuls test for multiple data sets. PϽ0.05 was considered significant.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
IP 3 R1 Is in Close Proximity to TRPC3 Channels in Cerebral Artery Myocytes
IP 3 R1 is the principal molecular and functional IP 3 R isoform that is expressed in myocytes of cerebral arteries and aorta. 5, 19 To explore spatial proximity between IP 3 R1 and 3 different TRP channel isoforms in cerebral artery myocytes, we used immunofluorescence resonance energy transfer. Specifically, spatial localization between IP 3 R1 and TRPC3, TRPC6, or TRPM4 channels was examined. Cy3-and Cy2-labeled secondary antibodies bound to primary antibodies targeting IP 3 R1 (monoclonal) and TRPC3 (polyclonal), respectively, produced mean N-FRET of Ϸ25% ( Figure 1A and 1B). In contrast, fluorescent antibodies bound to IP 3 R1 and TRPM4 (polyclonal), or IP 3 R1 and TRPC6 (polyclonal), generated mean N-FRET of Ϸ11% and Ϸ12%, respectively ( Figure 1A and 1B). ET-1 increased mean N-FRET between IP 3 R1 and TRPC3-bound antibodies to Ϸ34%. In contrast, N-FRET between IP 3 R1 and TRPC3-bound antibodies was not altered by membrane depolarization with 30 mmol/L K ϩ ( Figure 1B ). ET-1 did not change N-FRET between antibodies bound to IP 3 R1 and TRPC6 or IP 3 R1 and TRPM4 ( Figure 1A and 1B). Antigenic peptides for TRPC3, TRPC6, and TRPM4 specifically blocked immunofluorescence produced by each antibody, but did not alter immunofluorescence detection by the other 2 antibodies (Online Figure I, A) . Next, N-FRET was measured in myocytes in which TRPC3 or TRPC6 expression was reduced using short hairpin RNA and quantified using Western blotting. The selectivity of antibodies for Western blotting experiments was examined. Whole Western blots for IP 3 R1, TRPC3 and TRPC6 antibodies on arterial lysate are illustrated in Online Figure I (B). The monoclonal IP 3 R1 antibody detected only 1 band corresponding to IP 3 R1 (Online Figure I , B), and this band is reduced by IP 3 R1 knockdown, indicating specificity. 5 Antigenic peptides abolished appropriate size bands for each TRPC isoform but did not alter detection of the other TRPC protein (Online Figure I , C). The TRPC3 antibody detected recombinant TRPC3 expressed in HEK293 cells, but did not detect recombinant TRPC6 (Online Figure II, A) . Similarly, the TRPC6 antibody detected recombinant TRPC6, but did not detect recombinant TRPC3 (Online Figure II, A) . Endogenous TRPC3 and TRPC6 proteins were detected in HEK293 cells, consistent with a previous report. 20 Taken together, these data further indicate that the TRPC3 and TRPC6 antibodies are selective for their respective TRPC channel isoforms.
Western blotting indicated that TRPC3shV and TRPC6shV reduced mean TRPC3 and TRPC6 protein by Ϸ40 and 43%, respectively, of that in arteries treated with scrm ( Figure 1C and 1D). TRPC3shV did not alter TRPC6 and IP 3 R1 expression and TRPC6shV did not alter TRPC3 and IP 3 R1 expression ( Figure 1C and 1D ). TRPC3 knockdown reduced control N-FRET and the ET-1-induced elevation in N-FRET between IP 3 R1 and TRPC3 ( Figure 1E ). In contrast, TRPC6 knockdown had no effect on N-FRET between IP 3 R1 and TRPC6 in control or ET-1 ( Figure 1E ), indicating that this signal represents background N-FRET. Coimmunoprecipitation (co-IP) was used to examine whether IP 3 R1 physically associates with TRPC3 and TRPC6 channels in small cerebral arteries. Because of the small size of the resistance-size vessels used in this study, arteries collected from Ϸ20 rats were required for each experiment. The IP 3 R1 monoclonal antibody coimmunoprecipitated both IP 3 R1 and TRPC3 channels from lysate ( Figure 2 ). In contrast, TRPC6 was not detected in the same IP 3 R1 immunoprecipitate ( Figure 2 ).
In summary, data indicate that TRPC3, but not TRPM4 or TRPC6, is in close spatial proximity to, and associates with, IP 3 R1 channels in myocytes of resistance-size cerebral arteries. Data also demonstrate that ET-1 modifies the molecular relationship between IP 3 R1 and TRPC3.
TRPC3 Mediates IP 3 -Induced I Cat Activation in Cerebral Artery Myocytes
The contribution of TRPC3 and TRPC6 channels to IP 3 -induced I Cat was examined. The TRPC3 antibody blocked whole-cell currents generated by recombinant TRPC3 expressed in HEK293 cells (Figure 3A and 3B; Online Figure  II , B). In contrast, the TRPC3 antibody did not alter currents produced by recombinant TRPC6 channels. Similarly, the TRPC6 antibody blocked recombinant TRPC6 channel currents, but did not alter TRPC3 currents (Figure 3A and 3B; Online Figure II, B) . Therefore, the antibodies selectively inhibit their respective TRPC currents. The TRPC3 antibody reduced mean IP 3 -induced I Cat density by Ϸ57% in arterial myocytes ( Figure 3C and 3D) . In contrast, the TRPC6 antibody had no effect on IP 3 -induced I Cat density in arterial myocytes ( Figure 3C and 3D) .
IP 3 -induced I Cat activation and vasoconstriction were studied in myocytes and arteries in which TRPC3 or TRPC6 expression was reduced using short hairpin RNA. TRPC3 knockdown reduced IP 3 -induced I Cat density by Ϸ41%. In contrast, TRPC6 knockdown did not alter IP 3 -induced I Cat density ( Figure 4A and 4B). TRPC6 knockdown reduces myogenic tone at intravascular pressures Ͼ40 mm Hg. 10 Therefore, diameter regulation was measured in arteries pressurized to 20 mm Hg to avoid differences in baseline tone between arteries in which TRPC3 and TRPC6 were knocked down. TRPC3 knockdown attenuated IP 3 -and ET-1-induced vasoconstriction by Ϸ43 and 49%, respectively ( Figure 4C through 4E). In contrast, TRPC6 knockdown had no effect on IP 3 -and ET-1-induced vasoconstriction ( Figure 4C through 4E). These data indicate that TRPC3, but not TRPC6, channels mediate IP 3 -induced I Cat activation and contraction in cerebral artery myocytes.
ET-1 Does Not Increase Surface Expression of TRPC3 Channels in Myocytes
An increase in ion channel activity (NP o ) can occur because of both an elevation in the number of channels (N) and an increase in channel open probability (P o ). To investigate whether ET-1 alters plasma membrane TRPC3 channel protein, we used surface biotinylation. 17 Confirmation that biotin specifically labels surface proteins was obtained using biotin-treated arterial segments exposed to Texas Red-conjugated streptavidin (Online Figure III) . In addition, heat shock protein 90, an intracellular protein, was detected only in the nonbiotinylated (cytosolic) fraction ( Figure 5A ). Biotinylation indicated that in control, Ϸ30% of Mean data for current density generated in HEK293 cells in response to transfection with recombinant TRPC3 or TRPC6 channels and selective inhibition by TRPC3 and TRPC6 antibodies (2 g/mL each). Whole cell currents were essentially absent in cells transfected with only GFP. n values for columns from left to right are: 7, 7, 6, 6, 6, and 4, respectively. C, Exemplary recordings illustrating inhibition of IP 3 -induced (10 mol/L in pipette solution) I Cat by TRPC3 antibody (2 g/mL), but no effect of TRPC6 antibody (2 g/mL), in arterial myocytes. D, Mean data for active and denatured TRPC3 (nϭ8 each) and TRPC6 antibody (nϭ7 each) in arterial myocytes. *PϽ0.05 vs denatured control.
total TRPC3 protein was present in the arterial plasma membrane ( Figure 5B and 5C). ET-1 did not alter the percentage of plasma membrane-localized TRPC3 ( Figure 5B and 5C). These data indicate that a significant proportion of arterial TRPC3 is cytosolic and that ET-1 elevates myocyte I Cat by stimulating plasma membrane-resident TRPC3 channels.
Calmodulin and IP 3 R Binding Domains Are Present in Myocyte TRPC3 and TRPC6 Channels
Recombinant IP 3 R N-termini contain a conserved amino acid sequence that can interact with a conserved C-terminal CIRB (calmodulin and IP 3 R binding) domain found on all on TRPC isoforms. 21, 22 TRPM4 does not contain a CIRB domain (GenBank accession no. XM_574447). Our data indicate that isoform-selective association of TRPC3 channels to IP 3 R1 occurs in arterial myocytes (Figures 1 through 4) . Therefore, we used RT-PCR to investigate whether myocyte TRPC channels contain CIRB domains. Primers used were selective for TRPC3 and TRPC6 CIRB domains (Online Figure IV) . RT-PCR was performed on manually selected arterial myocytes to prevent message contamination from other vascular wall cell types. 18 Data indicated that the C-termini of arterial myocyte TRPC3 and TRPC6 channels contain CIRB domains ( Figure 6A ).
TRPC3-IP 3 R1 Physical Coupling Is Required for ET-1-and IP 3 -Induced I Cat Activation
We tested the hypothesis that IP 3 -induced I Cat activation in arterial myocytes occurs through an interaction between the conserved IP 3 R interaction domain and the TRPC CIRB domain. Synthetic peptides corresponding to a region in the TRPC3 CIRB domain (QIMKRLIKRYVLKAQVDKEND, CIRBP), [21] [22] [23] [24] and a scrambled control peptide (RDLKKAQNLVEIQKKYDRMVI, CIRBPscrm) were generated. CIRBP and CIRBPscrm alone did not alter mean baseline I Cat density (pA/pF: no peptide, Ϫ3.5Ϯ0.5, nϭ5; CIRBPscrm, Ϫ3.7Ϯ0.9, nϭ10; CIRBP, Ϫ2.9Ϯ0.6, nϭ11; PϾ0.05 for each) in arterial myocytes. In contrast, CIRBP reduced IP 3 and ET-1-induced I Cat activation by Ϸ63% and 60%, respectively, when compared with CIRBPscrm ( Figure 6B through 6D) .
To study physiological functions of the IP 3 R N terminus, a peptide was constructed corresponding to the IP 3 R N-terminal sequence containing the conserved TRPC-binding region (EEVWLFWRD, IP 3 RntP). IP 3 RntP increased mean I Cat density by Ϸ260% (Figure 7A and 7B). Gadolinium (Gd 3ϩ ), a nonselective cation channel blocker, had no significant effect on baseline currents, but reduced mean IP 3 RntPinduced I Cat density by Ϸ70% (Figure 7A and 7B) . These data indicate that physical association between the IP 3 R1 N terminus and the TRPC C terminus CIRB domain leads to I Cat activation in arterial myocytes. 
CIRBP Attenuates ET-1-and IP 3 -Induced Vasoconstriction
The physiological function of molecular coupling between IP 3 R and TRPC3 channels was investigated by measuring diameter regulation of pressurized (60 mm Hg) arteries. Membranepermeant CIRBP (CIRBP-TAT) and scrambled control (CIRBPscrm-TAT) peptides were each generated by conjugation to a HIV-1 TAT sequence (RRRQRRKKRGY). 25 CIRBP-TAT reduced vasoconstriction caused by Bt-IP 3 , a membrane permeant IP 3 analog, and ET-1 by Ϸ78% and Ϸ65%, respectively, when compared with CIRBPscrm-TAT ( Figure 8A through 8D) . These data indicate that interaction between the IP 3 R1 N terminus and the TRPC3 channel CIRB domain contributes to IP 3 and ET-1-induced vasoconstriction.
Discussion
Here, we identify a novel vasoregulatory signaling mechanism whereby IP 3 Rs couple to plasma membrane TRPC3 channels in arterial myocytes (Online Figure V) . Novel findings of this study are that in cerebral artery myocytes: (1) IP 3 R1 is located in close proximity to TRPC3, but not TRPC6 or TRPM4 channels; (2) ET-1 elevates FRET between fluorescent antibodies bound to IP 3 R1 and TRPC3 channels but does not alter FRET between IP 3 R1 and TRPC6 or TRPM4 channels; (3) TRPC3 channels co-IP with IP 3 R1, whereas TRPC6 channels do not; (4) TRPC3, but not TRPC6, channels underlie IP 3 -induced I Cat ; (5) ET-1 does not alter total or plasma membrane-localized TRPC3 channel protein; (6) TRPC3 and TRPC6 both contain CIRB domains; (7) a TRPC3 CIRB domain peptide reduces IP 3 -and ET-1-induced I Cat activation and a peptide corresponding to the IP 3 R1 N-terminal sequence that interacts with the TRPC CIRB domain activates I Cat ; and (8) CIRBP attenuates IP 3 -and ET-1-induced vasoconstriction. Taken together, these data indicate that IP 3 R1 activation causes physical coupling of the IP 3 R1 N terminus to the TRPC3 channel C terminus, leading to I Cat activation and vasoconstriction. Physical coupling between all IP 3 R and TRPC channel isoforms occurs with recombinant channels, [21] [22] [23] 26 To our knowledge, this is the first time that molecular coupling between IP 3 R1 and TRPC channels has been demonstrated to occur in a native cell type, to perform a physiological function, and to exhibit TRPC channel isoform selectivity. Our data also suggest that close spatial proximity of IP 3 R1 to TRPC3 channels establishes selective molecular coupling of these proteins. In contrast, although TRPC6 contains a CIRB domain, spatial separation appears to prevent this channel from coupling to IP 3 R1 in arterial myocytes. Our study demonstrates that arterial myocyte IP 3 R channels, previously considered to function solely by releasing SR Ca 2ϩ , directly activate TRPC3 channels, thereby regulating arterial contractility. This study also illustrates that manipulating physical coupling between IP 3 R1 and TRPC3 channels is a novel mechanism that could be exploited to regulate arterial contractility.
Rat cerebral artery myocytes express several TRP isoforms, including TRPC1, -3, -6, TRPM4, and TRPV4. 7,9 -11 Mammalian TRPC channel isoforms share Ͼ30% amino acid sequence identity, 27 with all TRPC channel isoforms containing a C-terminal CIRB domain. 21, 22 Cerebral artery myocytes express all 3 IP 3 R isoforms, with IP 3 R1 being the principal molecular and functional isoform. 5 All recombinant IP 3 R isoforms contain an N-terminal TRPC channel interaction domain. 21, 22 Coupling of the IP 3 R TRPC binding domain to the TRPC channel CIRB domain displaces inhibitory calmodulin, leading to channel activation. 22 The CIRB domain may also be a TRPC channel trafficking sequence. 24 These previous studies were performed primarily by studying recombinant channels. It has been proposed that the physical interaction between IP 3 Rs and TRPC channels may have occurred in response to TRPC channel overexpression. [21] [22] [23] 26 Therefore, it was unclear whether physical coupling between IP 3 Rs and TRPC channels would occur in native cell types. Here, we demonstrate that this coupling mechanism does occur in a native cell type, selectively regulates TRPC3 currents in arterial myocytes, and leads to vasoconstriction.
In cerebral artery myocytes, IP 3 R stimulation leads to the activation of a I Cat to which TRPC3 channels contribute. 4,9 IP 3 R-mediated I Cat activation leads primarily to Na ϩ influx, resulting in membrane depolarization, voltage-dependent Ca 2ϩ channel activation, an [Ca 2ϩ ] i elevation, and vasoconstriction. 4 The mechanism by which IP 3 Rs stimulate TRPC3 channels occurs independently of SR Ca 2ϩ release and appears to be a major mechanism by which PLC-coupled receptor agonists cause vasoconstriction. 4 IP 3 R1 and TRPC3 channels do not contribute to the cerebral artery myogenic response. 4, 9 In contrast, TRPC6 channels do not contribute to ET-1 or UTP-induced cerebral artery constriction, but are essential for the myogenic response. 4, 9, 10 The different mechanisms by which vasoconstrictors and IP 3 activate TRPC3, whereas intravascular pressure stimulates TRPC6 were unclear. Fluorescent antibodies bound to endogenous IP 3 R1 and TRPC3 generated FRET that was elevated by ET-1 and higher than for TRPC6 or TRPM4. TRPC3 knockdown reduced basal and ET-1-induced IP 3 R1/TRPC3 FRET. The calculated Förster distance between Cy2 and Cy3 is 5 to 6 nm, supporting other evidence in this study that IP 3 R1 and TRPC3 are close enough to physically interact. In contrast, the FRET signal between IP 3 R1 and TRPC6 and TRPM4 was consistent with background, 28 was not elevated by ET-1, and When applied alone, CIRBP-TAT and CIRBPscrm-TAT similarly reduced mean baseline diameter by Ϸ15 and 13 m, respectively, consistent with a previous report for the TAT sequence. 25 was not altered by TRPC6 knockdown. These data indicate that that TRPC6 and TRPM4 are not in close proximity to IP 3 R1. Mechanisms that position TRPC3 nearby IP 3 R1, but TRPC6 and TRPM4 away from IP 3 R1, are unclear. Several possibilities exist, including differential localization by local lipid environments, including caveolae. It is also possible that IP 3 R1 and TRPC3 are maintained by scaffolding proteins in a macromolecular complex. Scaffolding proteins, including Homer, establish close proximity of TRPC channels to other proteins, including IP 3 Rs. 29 The ET-1-induced elevation in immunofluorescence resonance energy transfer may occur because of an IP 3 -induced conformational change in IP 3 R1 that locates the Cy3-tagged antibody closer to Cy2-bound TRPC3. Alternatively, ET-1 may cause IP 3 R clustering, 30 thereby locating more Cy3-tagged IP 3 R1 channels in the vicinity of Cy2-bound TRPC3. The FRET method cannot differentiate between these potential mechanisms, but these possibilities deserve future investigation.
Co-IP data indicated that IP 3 R1 and TRPC3 are located in the same arterial macromolecular complex that does not contain TRPC6. The small arteries used for co-IP experiments inevitably contained endothelium. Complementary data, including those obtained using FRET, patch-clamp electrophysiology, RNA interference, antibodies and peptides, indicate that close spatial and functional interaction occurs between IP 3 R1 and TRPC3 in isolated myocytes. Arterial myocyte TRPC3 and TRPC6 channels both contained CIRB domains. Thus, although both TRPC3 and TRPC6 could interact molecularly with IP 3 R1, spatial proximity determines their ability to communicate. The CIRBP sequence used here as a competitive antagonist is identical to the sequence in TRPC3, and between 11% (TRPC1) and 89% (TRPC7) homologous to sequences in other TRPC channel isoforms. 24 The CIRBP peptide did not alter I Cat or diameter in the absence of ET-1 or IP 3 , but reduced ET-1 and IP 3 -induced I Cat activation and vasoconstriction. Additional support that the CIRB domain is functional in arterial myocytes was data indicating that IP 3 RntP stimulated a Gd 3ϩ -sensitive I Cat . The IP 3 RntP should activate all TRP channels that contain a CIRB domain, including TRPC3, regardless of their proximity to IP 3 Rs. However, TRPC isoforms also have variable affinities for the IP 3 R N terminus. 21 Taken together our data indicate that: (1) IP 3 R1 and TRPC3 proteins are maintained in close proximity in the absence of receptor agonists; (2) physical interaction between the IP 3 R1 N terminus and TRPC3 channel C terminus is weak in the absence of IP 3 , indicating that the interaction domains do not maintain the close proximity; and 3) IP 3 enhances physical interaction between IP 3 R1 and TRPC3. Although IP 3 R1 did not activate TRPC6, IP 3 R1 may activate TRPC isoforms other than TRPC3 in arterial myocytes. Given that there are seven TRPC isoforms and 3 IP 3 R isoforms, it was beyond the scope of the current study to determine which of the potential twenty-one interactions may occur molecularly and functionally in arterial myocytes. TRPC channel heteromultimers have been reported in cultured vascular myocytes and A7r5 cells, 31 but it is unclear whether TRPC channels that couple to IP 3 R1 in arterial myocytes are homomultimers or heteromultimers. TRPC3 knockdown reduced TRPC3 protein by Ϸ40% and attenuated IP 3 -induced I Cat by Ϸ41%. A TRPC3-selective antibody also similarly inhibited recombinant TRPC3 currents and IP 3 -induced I Cat in arterial myocytes. Therefore, any IP 3 -induced current mediated by channels other than TRPC3 would be small in arterial myocytes. In other native cell types, IP 3 Rs and TRPC channels may exhibit different isoform-dependent coupling patterns, including promiscuous coupling similar to that with recombinant channels.
Several stimuli, including receptor agonists, increase plasma membrane trafficking of recombinant TRPC3 channels. 32 Biotinylation indicated that over the same time course that ET-1 activated I Cat in arterial myocytes, total TRPC3 or plasma membrane-localized TRPC3 did not change. These data indicate that ET-1 elevates I Cat by increasing the P o of membrane-resident TRPC3 channels. Biotinylation also indicated that a large proportion of TRPC3 protein is intracellular. One explanation for these data are that TRPC3 channels may be retained, for example by RNF24, 33 and that signaling pathways other than those activated by acute ET-1 application may stimulate plasma membrane insertion. TRPC3 channels are also present on intracellular organelle membranes. 29 Given that FRET was detected at the plasma membrane and intracellularly, our data indicate that intracellular TRPC3 channels are also in close proximity to IP 3 R1. Protein complexes containing both IP 3 R1 and TRPC3 may also form before plasma membrane insertion of TRPC3. 29 PLC not only generates IP 3 , but also elevates DAG, which activates PKC. CIRBP reduced ET-1-and IP 3 -induced I Cat activation by Ͼ60%. These data indicate that ET-1 and IP 3 stimulate a I Cat primarily through molecular coupling of IP 3 Rs to TRPC channels, rather than through DAG and PKC activation. This conclusion is consistent with previous evidence that IP 3 R1 antibodies and IP 3 R1 knockdown also inhibit UTP-induced I Cat activation in arterial myocytes. 5 DAG and PKC can regulate TRPC channels, but in vascular myocytes isolated from a variety of different blood vessels, regulation is complex with studies reporting PKC-mediated activation, inhibition, or no effect. 14,34 -36 In cerebral artery myocytes, PKC stimulates a I Cat by elevating TRPM4 channel apparent micromolar Ca 2ϩ sensitivity. 37, 38 Here, in patch-clamp experiments, free intracellular Ca 2ϩ was strongly buffered using EGTA and ET-1-induced PKC activation would not stimulate TRPM4 channels. 37, 38 Conceivably, a proportion of the CIRBP-insensitive ET-1-induced vasoconstriction may occur because of PKC activation of other TRP channels, including TRPM4. Agonists also stimulate vasoconstriction via additional mechanisms, including activation of Ca 2ϩ waves and voltage-dependent Ca 2ϩ channels, and elevation of myofilament Ca 2ϩ sensitivity. 2, 3 In summary, we describe a novel mechanism by which IP 3 Rs regulate arterial diameter. Our data indicate that ET-1 and IP 3 activate membrane-resident TRPC3 channels in arterial myocytes by causing an interaction between the IP 3 R1 N-terminal TRPC channel interaction sequence and the C-terminal TRPC3 channel CIRB domain. We also provide a mechanism by which IP 3 R1 activation selectively stimulates TRPC3, but not TRPC6, channels and indicate that this occurs because of the close spatial proximity of these proteins which allows physical interaction. Physical coupling between IP 3 R1 and TRPC3 channels could be manipulated therapeutically to regulate arterial contractility and, thus, brain blood flow.
